Difamilast Ointment for Eczema
Trial Summary
What is the purpose of this trial?
This trial is testing a medicated cream called difamilast ointment on people aged 2 and older who have mild to moderate atopic dermatitis. The cream aims to reduce skin inflammation and itching. The study will check if the cream is safe and effective over several months.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it mentions that subjects using restricted medications, biologics, and alternative therapies are excluded. It's best to discuss your current medications with the trial team to see if they are allowed.
What data supports the effectiveness of the drug Difamilast Ointment 1% for eczema?
Is Difamilast Ointment safe for humans?
How is Difamilast ointment different from other eczema drugs?
Research Team
Uma S Atmuri, MPharm MS
Principal Investigator
Acrotech Biopharma Inc.
Eligibility Criteria
This trial is for individuals aged 2 years and older diagnosed with mild to moderate atopic dermatitis (AD), as defined by the American Academy of Dermatology. Participants must have had AD for at least three months, a treatable body surface area affected by AD of 3% or more, and be able to follow study procedures. Those with active skin infections, significant infections, using certain medications or therapies, or having severe depression are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants apply Difamilast ointment 1% to affected areas twice daily
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Difamilast Ointment 1%
Find a Clinic Near You
Who Is Running the Clinical Trial?
Acrotech Biopharma Inc.
Lead Sponsor